Skip to Content

Answers (1)

Official Answer by Drugs.com 9 Mar 2016
Praluent (generic name: alirocumab) is approved for the treatment of a genetic form of high cholesterol passed down through families (heterozygous familial hypercholesterolemia), and for patients with atherosclerotic heart disease (such as heart attacks or strokes) who require additional lowering of LDL (bad) cholesterol. Praluent works by inactivating a protein in the liver called proprotein convertase subtilisin kexin 9 (PCSK9). PCSK9 blocks the receptors that transport LDL into the liver for metabolism (break down). Without these receptors, more LDL (bad cholesterol) remains in the blood. So, by blocking PCSK9, more receptors are available to capture the bad LDL cholesterol for breakdown and removal from the blood. Lowering the LDL in the blood is better for the heart and can help to reduce the incidence of severe heart disease.
Votes: +0
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

How is Lartruvo administered?

Posted 5 days ago 1 answerFAQ by Drugs.com

What is the difference between Flublok and Flublok Quadrivalent?

Posted 5 days ago 1 answerFAQ by Drugs.com

How do you calculate the dosage for Carnexiv?

Posted 5 days ago 1 answerFAQ by Drugs.com

How is Cuvitru administered?

Posted 5 days ago 1 answerFAQ by Drugs.com

How is Troxyca ER formulated to be abuse deterrent?

Posted 5 days ago 1 answerFAQ by Drugs.com